{"id":"W4392787310","doi":"10.1136/rmdopen-2023-003855","title":"Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL","year":2024,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"UCB Pharma; National Institute for Health and Care Research","keywords":"Medicine; Psoriatic arthritis; Internal medicine; Placebo; Adverse effect; Psoriasis; Gastroenterology; Rheumatology; Incidence (geometry); Arthritis; Surgery; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002067391,0.0003731048,0.0007712535,0.0001019081,0.0003973577,0.0003976471,0.0001360938,0.00005214473,0.00002887241],"category_scores_gemma":[0.0001387324,0.0002323713,0.00002298093,0.0002808396,0.00007314656,0.000374065,0.0006979645,0.0001474607,0.000007040126],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000237849,"about_ca_system_score_gemma":0.0001068564,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004112214,"about_ca_topic_score_gemma":0.002651667,"domain_scores_codex":[0.9979839,0.0002291257,0.0003823398,0.000795511,0.0002899587,0.0003191878],"domain_scores_gemma":[0.9987373,0.0005768933,0.00008271175,0.0002898697,0.00007592572,0.0002372491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1294015,0.01006014,0.009759248,0.00002860543,0.001217767,0.001086441,0.0349306,5.273525e-7,0.0008586515,0.000008656587,0.0001953343,0.8124526],"study_design_scores_gemma":[0.1816562,0.02710256,0.7838945,0.001351186,0.0003694188,0.00002022893,0.0032396,0.00005696775,0.0003177727,0.00001044495,0.001654143,0.000327012],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849687,0.002468348,0.000001225373,0.00259829,0.00009853227,0.008476901,0.00134241,0.00002294879,0.00002259847],"genre_scores_gemma":[0.9984783,0.0005281965,0.0001152992,0.0002476212,0.00003407363,0.000302546,0.0001135599,0.00004519066,0.0001352377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8121256,"threshold_uncertainty_score":0.9475827,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05058052042586963,"score_gpt":0.330171936278087,"score_spread":0.2795914158522174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}